{
    "Trade/Device Name(s)": [
        "IDS SHBG",
        "IDS-iSYS SHBG assay"
    ],
    "Submitter Information": "Immunodiagnostic Systems Ltd",
    "510(k) Number": "K190121",
    "Predicate Device Reference 510(k) Number(s)": [
        "K151986"
    ],
    "Regulatory Class": "Class I, reserved",
    "Product Code(s)": [
        "CDZ"
    ],
    "Summary Letter Date": "May 15, 2019",
    "Summary Letter Received Date": "May 17, 2019",
    "Submission Date": "June 11, 2019",
    "Regulation Number(s)": [
        "21 CFR 862.1680"
    ],
    "Regulation Name(s)": [
        "Testosterone test system"
    ],
    "Analyte Class(es)": [
        "endocrine",
        "chemistry"
    ],
    "Analyte(s)": [
        "Sex hormone binding globulin (SHBG)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Serum tube",
        "Serum gel separator tube",
        "K2EDTA plasma tube"
    ],
    "Instrument(s)/Platform(s)": [
        "IDS-iSYS Multi-Discipline Automated System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescence immunoassay"
    ],
    "Methodologies": [
        "Immunoassay",
        "Chemiluminescent detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for IDS SHBG chemiluminescence immunoassay for quantitative determination of SHBG in serum and plasma using the IDS-iSYS Multi-Discipline Automated System",
    "Indications for Use Summary": "Intended for the quantitative determination of SHBG in human serum or plasma on the IDS System as an aid in the diagnosis of androgen disorders",
    "fda_folder": "Clinical Chemistry"
}